Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00871715 · ClinicalTrials.gov registry record · NA
Arm Rehabilitation Study After Stroke
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 361
- Enrollment target
NCT00871715: Completed NA study, sponsored by University of Southern California.
NCT00871715 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 361 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00871715, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 361 participants
- Enrollment target
Study Summary
This study is about arm and hand recovery after a stroke. The investigators are testing an experimental arm therapy called Accelerated Skill Acquisition Program (ASAP) which combines challenging, intensive and meaningful practice of tasks of the participant's choice compared to two standard types of therapy (usual and customary arm therapy totaling 30 hours and usual and customary arm therapy for a duration indicated on the therapy prescription). A second objective is to characterize current outpatient arm therapy (dosage \& content) following stroke for individuals who are eligible for ICARE. Eligible candidates must have had a stroke affecting an arm within the last 106 days.
Primary Outcome
Change from baseline to end-of-study (12 months post-randomization) in log-transformed time required to perform each of the 15 standardized tasks with each upper extremity.
Interventions
- BEHAVIORAL Accelerated Skill Acquisition Program (ASAP)
- BEHAVIORAL Dose-Equivalent Usual & Customary Care - DEUCC
- BEHAVIORAL Usual and Customary Care - UCC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 361 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-02 |
| Phase | NA |
What the finished NCT00871715 record still lists
NCT00871715 is an interventional study that assigns participants to a tested intervention. The registered 361 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 3 interventions - of which Accelerated Skill Acquisition Program (ASAP) is the first listed.
NCT00871715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00871715 about?
NCT00871715 is a clinical study titled "Arm Rehabilitation Study After Stroke". This study is about arm and hand recovery after a stroke. The investigators are testing an experimental arm therapy called Accelerated Skill Acquisition Program (ASAP) which combines challenging, intensive and meaningful practice of tasks of the participant's choice compared to two standard types of...
What is the current status of trial NCT00871715?
This trial is currently completed. It is a NA study. The enrollment target is 361 participants. The study started on 2009-06. Estimated completion is 2014-02.
What interventions are being tested in trial NCT00871715?
The interventions under investigation include: Accelerated Skill Acquisition Program (ASAP) (BEHAVIORAL), Dose-Equivalent Usual & Customary Care - DEUCC (BEHAVIORAL), Usual and Customary Care - UCC (BEHAVIORAL).
Who is sponsoring clinical trial NCT00871715?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00871715's enrollment target sits among peer trials
361 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05533697 · 361 participants · Phase 1
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia